Royal Bank Of Canada Avita Medical, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Avita Medical, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 737 shares of RCEL stock, worth $7,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
737
Previous 2,778
73.47%
Holding current value
$7,016
Previous $29,000
68.97%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RCEL
# of Institutions
77Shares Held
6.31MCall Options Held
28.8KPut Options Held
17.2K-
Black Rock Inc. New York, NY1.78MShares$17 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$13.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA598KShares$5.69 Million0.0% of portfolio
-
State Street Corp Boston, MA535KShares$5.09 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA261KShares$2.49 Million0.65% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $238M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...